Copyright
©The Author(s) 2023.
World J Clin Infect Dis. Nov 22, 2023; 13(4): 37-48
Published online Nov 22, 2023. doi: 10.5495/wjcid.v13.i4.37
Published online Nov 22, 2023. doi: 10.5495/wjcid.v13.i4.37
Table 1 Comparison of clinical data between the severe and non-severe groups of elderly patients with coronavirus disease 2019
Variables | Total (n = 328) | Non-severe (n = 246) | Severe (n = 82) | P value |
Age (yr) | 77.0 (68.0, 86.0) | 74.0 (64.0, 84.0) | 84.0 (75.0, 89.0) | < 0.001 |
Male sex | 155 (47.4) | 108 (43.9) | 47 (57.3) | 0.037 |
Vaccinations (times) | 0 (0, 0) | 0 (0, 2) | 0 (0, 0) | < 0.001 |
Comorbidities | ||||
Chronic respiratory disease | 37 (11.2) | 20 (7.8) | 17 (20.7) | 0.001 |
Hypertension | 185 (56.4) | 135 (54.8) | 50 (61.0) | 0.332 |
Diabetes mellitus | 65 (19.9) | 44 (17.8) | 21 (25.6) | 0.129 |
Coronary heart disease | 56 (17.0) | 40 (16.1) | 16 (19.5) | 0.478 |
Cerebral infarction | 64 (19.6) | 34 (13.5) | 30 (36.6) | < 0.001 |
Chronic kidney disease | 16 (4.8) | 7 (2.6) | 9 (11.0) | 0.002 |
Immune system disease | 6 (1.9) | 5 (2.2) | 1 (1.2) | 0.589 |
Neoplastic disease | 31 (9.6) | 23 (9.6) | 8 (9.8) | 0.96 |
Neurodegenerative diseases | 23 (7.1) | 8 (3.0) | 15 (18.3) | < 0.001 |
Other comorbidities | 99 (30.1) | 69 (27.8) | 30 (36.6) | 0.138 |
Symptoms | ||||
Fever | 61 (18.6) | 33 (13.0) | 28 (34.1) | < 0.001 |
Pharyngodynia | 58 (17.6) | 41 (16.5) | 17 (20.7) | 0.39 |
Cough | 149 (45.5) | 98 (39.6) | 51 (62.2) | < 0.001 |
Nasal stuffiness | 31 (9.6) | 18 (7.4) | 13 (15.8) | 0.026 |
Diarrhea | 3 (1.0) | 1 (0.4) | 2 (2.4) | 0.11 |
Other symptoms | 21 (6.4) | 9 (3.5) | 12 (14.6) | < 0.001 |
Laboratory data | ||||
D-dimers (mg/ml) | 0.66 (0.30, 1.85) | 0.42 (0.21, 0.82) | 3.19 (1.33, 7.32) | < 0.001 |
eGFR (ml/min/1.73 m2) | 76.63 ± 23.62 | 78.59 ± 20.82 | 71.09 ± 29.47 | 0.039 |
TNF-α (pg/ml) | 9.78 (7.47, 12.60) | 8.85 (7.12, 11.10) | 12.37 (10.90, 18.80) | < 0.001 |
IL-10 (pg/ml) | 5.00 (5.00, 5.82) | 5.00 (5.00, 5.00) | 6.47 (5.24, 8.99) | < 0.001 |
IL-1β (pg/ml) | 5.00 (5.00, 5.55) | 5.00 (5.00, 5.00) | 5.55 (5.00, 7.17) | < 0.001 |
PCT (ng/ml) | 1.58 ± 6.76 | 0.14 ± 0.57 | 5.66 ± 12.31 | < 0.001 |
CRP (mg/L) | 23.41 ± 38.25 | 9.83 ± 21.20 | 61.96 ± 48.30 | < 0.001 |
WBC (109/L) | 6.82 ± 3.29 | 5.92 ± 1.93 | 9.36 ± 4.72 | < 0.001 |
Neutrophil percentage | 69.80 ± 14.30 | 64.44 ± 11.38 | 85.02 ± 10.22 | < 0.001 |
Lactic acid (mmol/L) | 1.80 (1.37, 2.30) | 1.64 (1.25, 2.00) | 2.47 (1.81, 3.20) | < 0.001 |
SIRI | 3.45 ± 5.08 | 1.71 ± 1.93 | 8.36 ± 7.48 | < 0.001 |
NLR | 5.27 ± 5.58 | 3.19 ± 3.05 | 11.17 ± 6.79 | < 0.001 |
Oxygen saturation | 96.13 (93.00, 97.13) | 96.60 (95.98, 97.73) | 91.00 (89.00, 92.90) | < 0.001 |
Treatment | ||||
Respiratory support | 108 (33.01) | 29 (10.44) | 79 (96.34) | < 0.001 |
Paxlovid | 196 (59.62) | 148 (60.00) | 48 (58.54) | 0.817 |
Glucocorticoids | 78 (23.72) | 24 (8.70) | 54 (65.85) | < 0.001 |
Anticoagulation (low molecular weight heparin or regular heparin) | 98 (29.81) | 42 (16.09) | 56 (68.29) | < 0.001 |
Lianhua Qingwen Granule | 212 (64.74) | 169 (69.13) | 43 (52.44) | 0.007 |
Antibiotics | 113 (34.30) | 46 (17.39) | 67 (81.71) | < 0.001 |
Length of hospital stays (d) | 8 (5, 11) | 7 (5, 10) | 8 (5, 14) | 0.011 |
Viral shedding time (d) | 9.25 ± 5.84 | 8.65 ± 4.87 | 10.95 ± 7.74 | 0.014 |
Death | 15 (4.57) | 0 (0.00) | 15 (18.29) | < 0.001 |
Table 2 Univariate and multivariate analysis of the development of severe infection in elderly patients with coronavirus disease 2019
Variables | Univariate analysis OR (95%CI) | P value | Multivariate analysis OR (95%CI) | P value |
Age | 1.084 (0.978, 1.202) | 0.126 | - | - |
Sex | 0.575 (0.1, 3.322) | 0.536 | - | - |
Vaccinations | 0.636 (0.039, 10.385) | 0.751 | - | - |
Chronic respiratory disease | 0.559 (0.025, 12.453) | 0.713 | - | - |
Diabetes mellitus | 7.76 (0.446, 134.92) | 0.16 | - | - |
Hypertension | 3.267 (0.365, 29.275) | 0.29 | - | - |
Coronary heart disease | 0.142 (0.01, 1.926) | 0.142 | - | - |
Cerebral infarction | 7.757 (0.704, 85.443) | 0.094 | 4.26 (1.012, 17.937) | 0.048 |
Chronic kidney disease | 0.057 (0.001, 4.578) | 0.2 | - | - |
Neurodegenerative diseases | 19.385 (0.149, 2527.003) | 0.233 | - | - |
Neoplastic disease | 0.527 (0.022, 12.846) | 0.695 | - | - |
Immune system disease | 0 (0, 203.169) | 0.213 | - | - |
WBC | 1.096 (0.669, 1.794) | 0.716 | - | - |
Neutrophil percentage | 1.125 (0.95, 1.331) | 0.172 | - | - |
eGFR | 1.044 (0.966, 1.128) | 0.281 | - | - |
NLR | 1.017 (0.636, 1.626) | 0.943 | - | - |
SIRI | 1.003 (0.534, 1.883) | 0.993 | - | - |
CRP | 1.023 (0.984, 1.063) | 0.251 | - | - |
PCT | 1.552 (0.67, 3.598) | 0.305 | - | - |
Oxygen saturation | 0.513 (0.369, 0.714) | 0.000 | 0.573 (0.451, 0.728) | 0.000 |
Lactic acid | 0.768 (0.269, 2.194) | 0.622 | - | - |
D-dimers | 1.156 (0.754, 1.772) | 0.507 | 1.394 (1, 1.944) | 0.05 |
Viral shedding time | 1.066 (0.892, 1.274) | 0.484 | - | - |
Lianhua Qingwen Granule | 0.486 (0.055, 4.302) | 0.517 | - | - |
Paxlovid | 2.505 (0.19, 33.049) | 0.485 | - | - |
- Citation: Liu XQ, Lu GZ, Yin DL, Kang YY, Zhou YY, Wang YH, Xu J. Analysis of clinical characteristics and risk factors between elderly patients with severe and nonsevere Omicron variant infection. World J Clin Infect Dis 2023; 13(4): 37-48
- URL: https://www.wjgnet.com/2220-3176/full/v13/i4/37.htm
- DOI: https://dx.doi.org/10.5495/wjcid.v13.i4.37